Optimizing treatment with Bcr-Abl tyrosine kinase inhibitors in Philadelphia chromosome-positive chronic myeloid leukemia: Focus on dosing schedules

Elias Jabbour, Jorge E. Cortés, Hagop Kantarjian

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Optimizing treatment with Bcr-Abl tyrosine kinase inhibitors in Philadelphia chromosome-positive chronic myeloid leukemia: Focus on dosing schedules'. Together they form a unique fingerprint.

Medicine & Life Sciences